Want to see TSE:DM full AI Analyst Report?
Top Page
Datametrex AI
(DM)
Select Model
Select Model
Rating:45Neutral
Price Target:
C$0.04
▲(46.67% Upside)
Action:Reiterated
Date:09/12/26
The score is primarily constrained by weak financial performance: heavy losses, ongoing cash burn, and negative equity that elevates solvency/financing risk, despite strong recent revenue growth. Technicals are modestly supportive in the short-to-medium term (above key shorter moving averages), but momentum appears stretched and the price remains below the 200-day average. Valuation is also limited by negative earnings (negative P/E) and no dividend data support.
Positive Factors
Strong Revenue Rebound
The sharp TTM revenue rebound indicates renewed customer demand and improved commercial traction in the company’s AI, analytics, and security activities. If sustained, stronger sales can expand operating scale, support reinvestment, and provide a larger base from which to pursue durable growth.
Negative Factors
Severe Unprofitability
The company remains far from breakeven despite the revenue rebound, with losses extending beyond normal early-stage investment levels and gross profit slightly negative. Persistent margin weakness limits internal funding capacity and makes future growth dependent on significant operating improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Rebound
The sharp TTM revenue rebound indicates renewed customer demand and improved commercial traction in the company’s AI, analytics, and security activities. If sustained, stronger sales can expand operating scale, support reinvestment, and provide a larger base from which to pursue durable growth.
Read all positive factors
Datametrex AI (DM) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$6.87M
Dividend YieldN/A
Average Volume (3M)208.28K
Price to Earnings (P/E)―
Beta (1Y)2.19
Revenue Growth15.20%
EPS Growth18.72%
CountryCA
Employees21
SectorGeneral
Sector StrengthN/A
IndustryInformation Technology Services
Share Statistics
EPS (TTM)-0.13
Shares Outstanding152,586,000
10 Day Avg. Volume115,063
30 Day Avg. Volume208,278
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)0.63
Price to Sales (P/S)1.11
P/FCF Ratio-2.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Datametrex AI Business Overview & Revenue Model
Company Description
Datametrex AI Limited, alongside its various divisions, specializes in leveraging proprietary machine learning and artificial intelligence technologies to gather, process, and present both structured and unstructured data. The company conducts its...
How the Company Makes Money
Datametrex AI makes money primarily by selling its software, analytics, and related professional services to customers. Key revenue streams are: (1) fees from AI/data analytics solutions (e.g., licensing and/or subscription-type access to analytic...
Datametrex AI Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
22
Negative
Cash Flow
20
Very Negative
| Breakdown | TTM | Dec 2025 | Jun 2025 | Mar 2024 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.47M | 5.19M | 6.49M | 7.80M | 30.49M | 49.03M |
| Gross Profit | -177.23K | -695.90K | 3.07M | 2.17M | 10.20M | 21.03M |
| EBITDA | -4.22M | -4.48M | -1.24M | -6.95M | -13.46M | 13.29M |
| Net Income | -12.65M | -5.95M | -3.06M | -19.14M | -17.26M | 9.09M |
Balance Sheet | ||||||
| Total Assets | 4.59M | 14.59M | 4.99M | 12.71M | 36.00M | 42.64M |
| Cash, Cash Equivalents and Short-Term Investments | 1.13M | 1.88M | 427.11K | 1.13M | 9.41M | 17.99M |
| Total Debt | 2.16M | 4.93M | 1.84M | 5.19M | 4.53M | 253.77K |
| Total Liabilities | 5.66M | 5.55M | 4.33M | 11.70M | 13.23M | 10.15M |
| Stockholders Equity | -1.07M | 9.05M | 656.40K | 1.00M | 22.77M | 32.49M |
Cash Flow | ||||||
| Free Cash Flow | -3.23M | -2.83M | -1.57M | -6.94M | -2.28M | 11.42M |
| Operating Cash Flow | -3.23M | -2.83M | -1.22M | -5.62M | -249.09K | 11.45M |
| Investing Cash Flow | 15.01K | 32.51K | 59.10K | -969.15K | -3.79M | -234.41K |
| Financing Cash Flow | 3.97M | 4.18M | 1.21M | -254.18K | -2.40M | 2.19M |
Datametrex AI Technical Analysis
Negative
0.03
Price Trends
0.09
Negative
0.09
Negative
Market Momentum
>-0.01
Positive
39.78
Neutral
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:DM, the sentiment is Negative. The current price of 0.03 is below the 20-day moving average (MA) of 0.09, below the 50-day MA of 0.09, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 39.78 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:DM.
Datametrex AI Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | C$44.44M | 1.44 | 42.45% | ― | 53.53% | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
48 Neutral | C$104.58M | -0.48 | -58.44% | ― | -3.81% | -275.71% | |
47 Neutral | C$111.28M | -2.66 | -27.81% | ― | -3.88% | -1119.52% | |
45 Neutral | C$6.87M | -0.34 | -532.72% | ― | 15.20% | 18.72% | |
44 Neutral | C$3.87M | -6.52 | 191.65% | ― | 12.49% | 30.43% |
* General Sector Average
TSE:DM
Datametrex AI
0.05
-0.04
-43.75%
TSE:KNR
Kontrol Technologies
2.50
0.00
0.00%
TSE:VIS
Visionstate
0.02
>-0.01
-25.00%
TSE:ALYA
Alithya Group
1.15
-0.51
-30.72%
TSE:SPOT
GoldSpot Discoveries
0.32
0.12
61.54%
Datametrex AI Corporate Events
Business Operations and StrategyFinancial Disclosures
Datametrex to Exit Healthcare Clinics and Double Down on AI and Patent Licensing
Positive
Sep 2, 2026
Datametrex AI Limited has begun winding down its healthcare operations, including multi-disciplinary medical clinics in Edmonton, Calgary and Vancouver, to concentrate capital and management resources on its core businesses in AI, data centre tech...
Business Operations and StrategyExecutive/Board ChangesDelistings and Listing Changes
Datametrex Rebrands as Quanta AI and Revamps Executive Leadership
Positive
Sep 1, 2026
Datametrex AI Limited, which will rebrand as Quanta AI Inc., is changing its corporate name and TSX Venture Exchange ticker to QNTA, with trading under the new identity expected to begin around mid-September 2026. Existing shareholders are not req...
Business Operations and StrategyExecutive/Board ChangesShareholder Meetings
Datametrex Shareholders Back Governance Changes and Name Change at Annual Meeting
Positive
Aug 31, 2026
Datametrex AI reported that shareholders at its August 28, 2026 annual and special meeting approved all resolutions, with 16.778% of outstanding shares represented in person or by proxy. Investors backed the election of four directors, re-approved...
Business Operations and StrategyRegulatory Filings and Compliance
Datametrex Shifts to Semi-Annual Financial Reporting to Cut Administrative Burden
Neutral
Aug 26, 2026
Datametrex AI Limited has announced that it will transition from quarterly to semi-annual financial reporting under Canadian securities exemptions for certain venture issuers. The company’s fiscal year ends March 31, and it will now report r...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.